Company Overview and News

Top 10 Silver Mining Stocks For 2018

2018-02-13 seekingalpha
Above are my Top 10 silver mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher silver prices. They are on this list primarily because of their upside potential. These are all producers except for one development stock (Bear Creek Mining).
Upvote Downvote

Eagle Energy: A Solid Portfolio Of Assets

2018-02-06 seekingalpha
The little-known Eagle Energy has amassed a portfolio of assets of adequate quality through arbitrage and acquisitions mostly done at the industry trough.
Upvote Downvote

Former Carillion bosses to give explosive tesimony to MPs and try to pin blame on Qataris

Zafar Khan, Carillion’s former ­finance chief, is preparing to give explosive testimony to MPs on Tuesday shining a light on how spiralling debts and missed payments by its clients took down the company.
Upvote Downvote

Mumbai: Politicians welcome move to break FDs, say BMC not money-making organization

Mumbai: The civic commissioner Ajoy Mehta on Friday announced for the first time that it has decided to use Fixed Deposit (FD) money on major projects. Out of Rs 70,000 crore the Brihanmumbai Municipal Corporation (BMC) plans to withdraw Rs 3,000 crore for the coastal road project, Goregaon Mulund Link Road(GMLR). The opposition and the ruling party politicians have applauded the move.
Upvote Downvote

Top 20 Gold Mining Stocks For 2018

2018-01-02 seekingalpha
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
Upvote Downvote

Maharashtra: State cabinet rejects proposal hike in MLA pension

Mumbai: The state cabinet on Tuesday rejected the proposal to hike the pension of sitting and former legislators from Rs 40,000 per month to Rs 50,000 on the ground of stressed financial situation of the state. If the proposal is approved, the state would have to take burden of more than Rs 7 crore per year.
Upvote Downvote Doubles Packet Throughput Performance to Terabit Levels

2017-07-11 prnewswire
SAN FRANCISCO, July 11, 2017 /PRNewswire-USNewswire/ ("Fido"), relentlessly focused on data IO speed and efficiency supporting the creation of high performance, flexible, and scalable software defined infrastructures, today announced significant performance gains reaching terabit levels at multimillion route scale. Architectural improvement increases in latest Intel® Xeon® Scalable processor family – such as increased PCIe bandwidth – allow FD.
Upvote Downvote

Fast Data ( Project Issues Fourth Release, Furthers Position as Universal Dataplane

2017-06-08 prnewswire 17.04 release enables a broad set of commercial-ready solutions such as the FRINX Distribution; Inocybe's High Performance Packet Processing Stack; and Netgate's pfSense
Upvote Downvote

Top 15 Gold And Silver Mining Stock Takeover Targets: Which One Is Most Likely?

2017-04-04 seekingalpha
Below is my list of the top gold & silver mining stock takeover targets. None of them are producers, but they all have very lucrative properties. Plus, they are all undervalued. Most of them have very advanced projects.
Upvote Downvote

20 Best Risk/Reward High Return Gold & Silver Mining Stocks For 2017

2017-01-01 seekingalpha
Last January I posted an article of the 20 best risk/reward high return gold & silver mining stocks. Someone asked me to do it again for 2017. There are six holdovers from last year, and 14 new stocks. This list includes the top 20 stocks with the best risk/reward characteristics to become 5+ baggers in the long term at higher gold and silver prices. Most of these stocks are dependent on higher gold/silver prices, giving them a higher degree of risk than a low cost producer.
Upvote Downvote

Fibrous Dysplasia Foundation and NORD Launch Cutting-Edge Study of Fibrous Dysplasia/McCune-Albright Syndrome

2016-11-03 marketwired
The research study is open to participants worldwide to advance understanding and treatments for a rare disease affecting the bone, skin and endocrine organs
Upvote Downvote

USFDA bans products from Laxachem Organics

2016-09-20 livemint
The USFDA placed Laxachem Organics on import alert 99-32 that allows detention without physical examination of products from firms refusing FDA foreign establishment inspection
Upvote Downvote

USFDA bans products from Laxachem Organics

2016-09-20 moneycontrol
The US Food and Drug Administration (USFDA) has placed Laxachem Organics Pvt Ltd on import alert 99-32 that allows detention without physical examination of products from firms refusing FDA foreign establishment inspection, FDA said on its website.
Upvote Downvote

United Utilities Group's (UUGRY) CEO Steve Mogford on Full Year Results - Earnings Call Transcript

2016-05-26 seekingalpha
United Utilities Group PLC ADR (OTCPK:UUGRY) Full Year Earnings Conference Call May 26, 2016 4:00 AM ET
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...